JPRN-UMIN000032376已完成未知
A Feasibility Study of Carboplatin/Paclitaxel/Nivolumab with Concurrent Thoracic Radiotherapy in Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer - A Feasibility Study of Carboplatin/Paclitaxel/Nivolumab with Concurrent Thoracic Radiotherapy in Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer
Department of Thoracic Oncology, Kansai Medical University Hospiital0 个研究点目标入组 10 人开始时间: 2018年4月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 74years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Double cancer 2) Interstitial pneumonia or pulmonary fibrosis 3) Diverticulitis or peptic ulcer 4) Severe lung disease, for example, emphysema, chronic bronchitis and bronchial asthma 5) Drug-induced interstitial pneumonia or severe drug allergy 6) Active tuberculosis or treatment history of tuberculosis 7) History of anaphylaxis induced by other antibody preparation 8) Uncontrollable diabetes 9) Active autoimmune disease 10) Peripheral neuropathy (>Grade 2) 11) Patients who received transplantation therapy 12) Patients who are receiving continuous systemic administration of steroids or immunosuppressants 13) The patient received or is scheduled to receive a live or attenuated vaccine within 28 days before the first dose of the investigational product 14) History of treatment for T cell regulation
研究者
相似试验
招募中
2 期
Feasibility study evaluating Paclitaxel, Carboplatin and Cetuximab (PCE) as induction chemotherapy followed by chemoradiation in patients with Unresectable Locally advanced Squamous Cell Carcinoma of the Head and NeckJPRN-jRCTs031180358Tahara Makoto46
招募中
2 期
Feasibility study evaluating Paclitaxel, Carboplatin and Cetuximab (PCE) as induction chemotherapy followed by chemoradiation in patients with Unresectable Locally advanced Squamous Cell Carcinoma of the Head and NeckHead and Neck cancerJPRN-UMIN000014430IC-PCE study executive committee34
已完成
不适用
Feasibility study of carboplatin, paclitaxel and bevacizumab in advanced non-squamous non-small-cell lung cancer with idiopathic interstitial pneumoniasAdvanced non-squamous non-small-cell lung cancer with idiopathic interstitial pneumoniasJPRN-UMIN000008189The Ministry of Health, Labour and Welfare of Japan awarded to the Study Group on Diffuse Pulmonary Disorders, Scientific Research/Research on intractable diseases27
已完成
1 期
A Phase I Study of Carboplatin and nab-Paclitaxel plus concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancernon small cell lung cancerJPRN-UMIN000013223Kochi University12
已完成
2 期
Phase II study of Carboplatin plus nab-Paclitaxel for advanced non-small cell lung cancer patients with interstitial lung diseaseAdvanced non-small cell lung cancer with interstitial lung diseaseJPRN-UMIN000012989Kanagawa Cardiovascular and Respiratory Center90